Christopher Posner is the founder of Cara Therapeutics. Cara Therapeutics has raised $56M in total funding. Latest round: Series D.
Christopher Posner is the President and Chief Executive Officer of Cara Therapeutics, a clinical-stage biopharmaceutical company based in Stamford, Connecticut. The company focuses on developing novel chemical entities to alleviate pruritus and fibrosis-driven diseases, with a lead product candidate KORSUVA. Cara Therapeutics secured $40 million in a December 2023 funding round to support product development.
Full founder directory · Investor directory · Company funding database · Fundraising library